Home > PJ (current issue) > The Society / News Centre | Search

The Pharmaceutical Journal
Vol 276 No 7396 p45xx
15 April 2006


Society summary


Council considers broader remit for BRM

Expanding the remit of the branch representatives' meeting to include motions from the Society's new national pharmacy boards and its membership groups was considered at the Royal Pharmaceutical Society's April Council meeting, when the Council approved background information for publication with the branch motions and the branches' explanatory paragraphs (see p455 PDF (70K)).

John Gentle (Council sponsor for the branches) said that there had been some concern about whether the BRM’s current format made best use of members’ time and the resources invested in the meeting. The Council had therefore agreed in 2005 to consult members on the future of the BRM, and a number of discussions had been held. A clear wish to make the meeting more relevant and strategic had to be balanced against the members’ view that the format of the meeting was part of their democratic entitlement.

Mr Gentle added that the branch secretaries had put forward the idea that the membership groups and the national boards should be able to put a limited number of motions to the BRM. The 2006 BRM would be asked for its views on that suggestion.

One clear theme was that branches wanted more support for formulating motions. A toolkit to help them identify outward looking and strategic motions for debate was to be launched at this year’s BRM.

The President pointed out that if branches wanted the Council to take some action, they did not have to wait to put a motion to the next BRM. They were free to write to the President or the Secretary and Registrar. The Council would then get to the task quicker.

The President added that equivalent meetings in other health care professions tended to be much more strategic. He could find nothing in the BRM motions about the Foster review, Section 60, pharmacist prescribing, the new contract, the NHS, hospital practice or the pharmaceutical industry. “We need to consider how to work with branches so that more strategic dialogue takes place between the Council, the branches and our members.” There was nothing wrong with the motions to be presented to us, because they are based on pharmacists’ experience in their daily life, but some long-term thinking might also be useful.

Mr Gentle suggested that the President’s idea about more strategic motions would probably be solved if the national boards and the sectional groups were allowed to put motions to the meeting.

Alan Kershaw said that if the dialogue happened only at branch representatives’ meetings in adversarial debate on motions then the process was too confrontational. The Council could be more positive and constructive in the way it worked with the branches all year around.

Back to Top


©The Pharmaceutical Journal